Pre-investment (FY2020)

Revenue$18.3M

EBITDA margin24%

Gross margin38%

Headcount~21 FTE

Finance debtHire purchase only

Countries69

Post-investment (FY2022)

Revenue$46.7M+155%

EBITDA margin26%held

Gross margin43%+5pts

Headcount63 FTE+200%

Finance debtNone of significance

Countries90+

Sources: Companies House full accounts, Horse Health Wessex Ltd / LeMieux Ltd (04656887). FY2020 year ended 30 April 2020; FY2022 year ended 25 April 2022. Both audited. Headcount: FY2020 from FY2019 filing (21 employees); FY2022 from strategic report. All figures in USD at $1.27/GBP.